Benzinga··Vandana SinghJ&J Pursues Strategic Divestiture of DePuy Synthes Orthopedics Unit
J&J plans to divest DePuy Synthes orthopedics unit valued at $20-28 billion. Private equity firms are negotiating potential acquisition bids as part of J&J's portfolio restructuring strategy.
JNJprivate equityearnings beat